Mesa Biotech to Launch Molecular, Sample-to-Answer RSV Test at the 2019 AACC Annual Scientific Meeting

Mesa Biotech Inc., a privately-held, molecular diagnostic company that has developed an affordable, sample-to-answer, CLIA-waived PCR (polymerase chain reaction) testing platform designed specifically for point-of-care (POC) infectious disease diagnosis, today announced the launch of its respiratory syncytial virus test (RSV). Mesa will demonstrate its expanded, novel Accula™ Test System at the 71st American Association of Clinical Chemistry (AACC) Annual Meeting and Clinical Lab Expo. The Accula System’s RSV and Flu A/Flu B molecular tests will be on exhibit in Booth 3902. Sekisui Diagnostics distributes both products in the US under the Silaris™ brand.

Web Industries showcases automated manufacturing solutions for LFI and medical diagnostic devices at AACC 2019

MARLBOROUGH, Mass. – July 25, 2019 – Medical device OEMs in search of commercialization and manufacturing solutions for lateral flow immunization (LFI) and medical diagnostic devices will discover several new capabilities and services that virtually eliminate product variability, improve overall quality and lower costs from contract manufacturer (CMO) Web Industries at AACC 2019, August 4 – 8, Anaheim Convention Center.